Przejdź do zawartości
Merck

Acute urinary retention secondary to buprenorphine administration.

The American journal of emergency medicine (2013-10-16)
Ryan T Edwards, Catherine McCormick-Deaton, Avinash Hosanagar
ABSTRAKT

Urinary retention is associated with buprenorphine, particularly with epidural/intrathecal delivery. However, it is rare with oral administration. This case report illustrates an occurrence of acute urinary retention after initiation of oral buprenorphine/naloxone.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Buprenorphine solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Buprenorphine hydrochloride solution, analytical standard, for drug analysis
Supelco
Buprenorphine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®